Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

Bio-Techne Stock Outlook: Is Wall Street Bullish or Bearish?

Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions dedicated to advancing biomedical research and diagnostics. With a market cap of $10.4 billion, Bio-Techne develops innovative reagents, instruments, and diagnostic tools that support healthcare providers, laboratories, and researchers in the life sciences industry.

Shares of Bio-Techne have underperformed the broader market over the past year. The stock has declined 6% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 22.3%. In 2025, the stock is down 8.5%, while SPX has gained 4% on a YTD basis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.